295 related articles for article (PubMed ID: 21777176)
1. Risk of acute kidney injury after exposure to gadolinium-based contrast in patients with renal impairment.
Chien CC; Wang HY; Wang JJ; Kan WC; Chien TW; Lin CY; Su SB
Ren Fail; 2011; 33(8):758-64. PubMed ID: 21777176
[TBL] [Abstract][Full Text] [Related]
2. The safety of gadolinium in patients with stage 3 and 4 renal failure.
Ergün I; Keven K; Uruç I; Ekmekçi Y; Canbakan B; Erden I; Karatan O
Nephrol Dial Transplant; 2006 Mar; 21(3):697-700. PubMed ID: 16326736
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
4. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.
Morabito S; Pistolesi V; Benedetti G; Di Roma A; Colantonio R; Mancone M; Sardella G; Cibelli L; Ambrosino M; Polistena F; Pierucci A
J Nephrol; 2012; 25(6):1098-107. PubMed ID: 22383347
[TBL] [Abstract][Full Text] [Related]
5. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis.
Maioli M; Toso A; Leoncini M; Gallopin M; Musilli N; Bellandi F
Circulation; 2012 Jun; 125(25):3099-107. PubMed ID: 22592896
[TBL] [Abstract][Full Text] [Related]
6. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
[TBL] [Abstract][Full Text] [Related]
7. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention.
Li XM; Cong HL; Li TT; He LJ; Zhou YJ
Chin Med J (Engl); 2011 Jul; 124(14):2101-6. PubMed ID: 21933609
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
[TBL] [Abstract][Full Text] [Related]
9. Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography.
Stolker JM; McCullough PA; Rao S; Inzucchi SE; Spertus JA; Maddox TM; Masoudi FA; Xiao L; Kosiborod M
J Am Coll Cardiol; 2010 Apr; 55(14):1433-40. PubMed ID: 20359592
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
Abu-Alfa AK
Adv Chronic Kidney Dis; 2011 May; 18(3):188-98. PubMed ID: 21531325
[TBL] [Abstract][Full Text] [Related]
11. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
Panesar M; Boateng F; Patel SS; Masood SF; Mahajan P; Patel N; Murray B
Hemodial Int; 2010 Jul; 14(3):289-94. PubMed ID: 20662951
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
[TBL] [Abstract][Full Text] [Related]
13. The impact of acute kidney injury on short-term survival in an Eastern European population with stroke.
Covic A; Schiller A; Mardare NG; Petrica L; Petrica M; Mihaescu A; Posta N
Nephrol Dial Transplant; 2008 Jul; 23(7):2228-34. PubMed ID: 17989102
[TBL] [Abstract][Full Text] [Related]
14. Incidence of nephrogenic systemic fibrosis at a large university hospital in Sweden.
Alhadad A; Sterner G; Svensson Å; Alhadad H; Leander P
Scand J Urol Nephrol; 2012 Feb; 46(1):48-53. PubMed ID: 22008005
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein levels and clinical symptoms following gadolinium administration in hemodialysis patients.
Schieren G; Tokmak F; Lefringhausen L; van Bracht M; Perings C; Willers R; Günsel A; Kemper F; Wiesmüller GA; Rump LC
Am J Kidney Dis; 2008 Jun; 51(6):976-86. PubMed ID: 18501785
[TBL] [Abstract][Full Text] [Related]
16. Comparison of risk factors for contrast-induced acute kidney injury between patients with and without diabetes.
Pakfetrat M; Nikoo MH; Malekmakan L; Tabande M; Roozbeh J; Ganbar Ali RJ; Khajehdehi P
Hemodial Int; 2010 Oct; 14(4):387-92. PubMed ID: 20796046
[TBL] [Abstract][Full Text] [Related]
17. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.
Manabe K; Kamihata H; Motohiro M; Senoo T; Yoshida S; Iwasaka T
Eur J Clin Invest; 2012 May; 42(5):557-63. PubMed ID: 22070248
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic system fibrosis: a radiologist's practical perspective.
Martin DR
Eur J Radiol; 2008 May; 66(2):220-4. PubMed ID: 18321672
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for contrast-related acute kidney injury according to risk, injury, failure, loss, and end-stage criteria in patients with coronary interventions.
Pakfetrat M; Nikoo MH; Malekmakan L; Tabande M; Roozbeh J; Reisjalali G; Zare N; Khajedehi P
Iran J Kidney Dis; 2010 Apr; 4(2):116-22. PubMed ID: 20404421
[TBL] [Abstract][Full Text] [Related]
20. Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention.
Andò G; de Gregorio C; Morabito G; Trio O; Saporito F; Oreto G
Circ Cardiovasc Interv; 2014 Aug; 7(4):465-72. PubMed ID: 25027519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]